AbstractChrysotile asbestos was administered to pregnant CD‐I mice in their drinking water and to Day 4 blastocysts during culture. Administration to pregnant mice did not affect embryo survival. In vitro administration of asbestos did not interfere with embryo implantation upon transfer of blastocysts to recipient females but did result in a decrease in postimplantation survival. These studies did not demonstrate asbestos to be teratogenic whether administered to the dam or to the blastocyst in vitro.